Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
April 19, 2012
Biopharmaceutical company. Strong grower. One of the few biotech companies that is making money and growing strong margins. Margins are growing at 20%-25% long-term growth. Trading at 16X.
Show full opinionHide full opinion
Celgene Corp (CELG-Q)
April 19, 2012
Biopharmaceutical company. Strong grower. One of the few biotech companies that is making money and growing strong margins. Margins are growing at 20%-25% long-term growth. Trading at 16X.
TOP PICK
TOP PICK
April 19, 2012
Looking for a definite catalyst later this year because he is anticipating the split into 2 companies, snacks and North American groceries. Snacks will be the higher growth, which will really benefit from international growth. The other will give a much higher dividend. Trades at a 8% discount to its peers.
Show full opinionHide full opinion
Looking for a definite catalyst later this year because he is anticipating the split into 2 companies, snacks and North American groceries. Snacks will be the higher growth, which will really benefit from international growth. The other will give a much higher dividend. Trades at a 8% discount to its peers.